Poseida Therapeutics, Inc. (PSTX)

$3.37 -6.65% $-0.24 Healthcare

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.

$327.34M

Mr. Mark J. Gergen J.D.

304.00

San Diego, CA

Dec 31, 1997

-2.86

$-1.18

1.00

4.61

-19.52%

-7.41

1.67

1.59

4.54

-10.87%

-17.55%

Similar stocks (14)

Revolution Medicines, Inc.

RVMD

$45.42 -1.65%
Uptrend

Cytokinetics, Incorporated

CYTK

$53.77 -3.29%
Downtrend

Dyne Therapeutics, Inc.

DYN

$36.59 0.49%
Neutral

Pliant Therapeutics, Inc.

PLRX

$12.14 -3.80%
Downtrend

Stoke Therapeutics, Inc.

STOK

$13.75 -9.18%
Uptrend

PepGen Inc.

PEPG

$9.20 -1.60%
Downtrend

Generation Bio Co.

GBIO

$2.78 -2.80%
Downtrend

Century Therapeutics, Inc.

IPSC

$1.70 0.00%
Downtrend

Lantern Pharma Inc.

LTRN

$3.99 -1.97%
Downtrend

Reviva Pharmaceuticals Holdings, Inc.

RVPH

$1.28 -2.29%
Downtrend

Passage Bio, Inc.

PASG

$0.68 -2.71%
Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.05 -2.78%
Downtrend

Cue Biopharma, Inc.

CUE

$0.52 -7.26%
Downtrend

IN8bio, Inc.

INAB

$0.31 -2.12%
Downtrend

ETF Exposure (30)

Global X Genomics & Biotechnology ETF

GNOM

0.35%

$11.32 -2.08%
Uptrend

iShares Micro-Cap ETF

IWC

0.04994%

$124.61 -1.53%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.01071%

$167.92 -1.45%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.01%

$206.72 -0.76%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$89.66 -1.02%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.01%

$148.28 -1.36%
Uptrend

iShares Russell 2000 ETF

IWM

0.00702%

$221.63 -1.04%
Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.0048311113%

$51.59 -0.71%
Uptrend

iShares Russell 2000 Growth ETF

IWO

0.00407%

$284.01 -0.62%
Uptrend

Dimensional U.S. Small Cap ETF

DFAS

0.00295607%

$64.49 -0.95%
Uptrend

ProShares Ultra Russell2000

UWM

0.0027556520791609924%

$43.13 -2.18%
Uptrend

ProShares UltraPro Russell2000

URTY

0.001358399438482691%

$52.46 -3.34%
Uptrend

ProShares Hedge Replication ETF

HDG

0.0011578422350286535%

$50.11 0.08%
Uptrend

Dimensional US Sustainability Core 1 ETF

DFSU

8.3238e-4%

$36.80 -0.49%
Uptrend

Dimensional US Core Equity Market ETF

DFAU

2.6208e-4%

$39.25 -0.38%
Uptrend

Schwab U.S. Broad Market ETF

SCHB

2.390191e-4%

$66.07 -0.26%
Uptrend

Dimensional U.S. Equity ETF

DFUS

1.2805e-4%

$61.54 -0.34%
Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

9.577e-5%

$33.96 -0.53%
Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

0%

$69.37 -1.21%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$252.12 -0.37%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$281.46 -0.21%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$181.71 -0.66%
Uptrend